PAUL SMITHSON: Open Payments
NPI 1780383109 · BROWNWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 10 payments from 8 companies in 2025. Trend: 2023 $801 · 2024 $984 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Myriad Genetic Laboratories, Inc. | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Eisai Inc. | 1 | $23 |
| SOBI, INC | 1 | $20 |
| PFIZER INC. | 1 | $18 |
| Gilead Sciences, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: OPDIVO, MYRISK, Enhertu, Lenvima, Vonjo, BOSULIF, Trodelvy, VERZENIO.
Industry payments across TX — which companies pay providers there.
